ACMD review of naloxone provision 2022

Two BDP workers holding naloxone in front of naloxone poster campaign

The Advisory Council on the Misuse of Drugs(ACMD) has published a self-commissioned review of the evidence on the provision and availability of naloxone in the UK. Naloxone is a medicine that can temporarily reverse the effects of opioids and is used as an emergency treatment for people suspected to be experiencing an opioid overdose. The review looks at the provision and availability of naloxone and has made a number of recommendations to optimise the use of naloxone to reduce drug-related harms.

BDP supply the majority of naloxone in the Bristol area and because of this we were asked to contribute to the report. We submitted information on the prevalence and provision of naloxone, how many people were carrying it, how many people are using it and a series of recommendations from our own experiences that would improve naloxone provision in the UK. This information was comprised of statistics from our records, along with input, opinions and case studies from BDP service users, people who have received naloxone training from BDP and our staff.

We welcome the recommendations put forward by the ACMD after gathering this wealth of evidence which include:

2 minute read

Related to this article

Celebrating National Volunteers' Week! 

Bristol Drug Project

Celebrating National Volunteers' Week! 

Happy National Volunteers’ Week from all of us at BDP!   This week provides us with the opportunity to celebrate...

Tree Planting in Memory of Maggie Telfer OBE

Bristol Drug Project

Tree Planting in Memory of Maggie Telfer OBE

Last week, we planted a tree in Brunswick Square just outside our offices in memory of Maggie Telfer OBE. Maggie was one of ...

International Women's Day 2024

Bristol Drug Project

International Women's Day 2024

This year’s International Women’s Day gives us a chance to reflect on women’s experience within our services a...